Brian Lenz
2021 - ADMA Biologics
In 2021, Brian Lenz earned a total compensation of $2.4M as Executive Vice President and Chief Financial Officer at ADMA Biologics, a 118% increase compared to previous year.
Compensation breakdown
| Bonus | $420,284 |
|---|---|
| Option Awards | $204,200 |
| Salary | $432,600 |
| Stock Awards | $1,146,250 |
| Other | $163,346 |
| Total | $2,366,680 |
Lenz received $1.1M in stock awards, accounting for 48% of the total pay in 2021.
Lenz also received $420.3K in bonus, $204.2K in option awards, $432.6K in salary and $163.3K in other compensation.
Rankings
In 2021, Brian Lenz's compensation ranked 5,378th out of 12,415 executives tracked by ExecPay. In other words, Lenz earned more than 56.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,378 out of 12,415 | 57th |
Division Manufacturing | 2,266 out of 5,505 | 59th |
Major group Chemicals And Allied Products | 987 out of 2,375 | 58th |
Industry group Drugs | 879 out of 2,096 | 58th |
Industry Biological Products, Except Diagnostic Substances | 217 out of 449 | 52nd |
Source: SEC filing on April 28, 2022.
Lenz's colleagues
We found two more compensation records of executives who worked with Brian Lenz at ADMA Biologics in 2021.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019